138 related articles for article (PubMed ID: 32717234)
21. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
Xia T; Li H; Sun Q; Wang Y; Fan N; Yu Y; Li P; Chang JY
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):117-25. PubMed ID: 16765528
[TBL] [Abstract][Full Text] [Related]
22. Role of salvage stereotactic body radiation therapy in post-surgical loco-regional recurrence in a selected population of non-small cell lung cancer patients.
Agolli L; Valeriani M; Carnevale A; Falco T; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Mar; 35(3):1783-9. PubMed ID: 25750343
[TBL] [Abstract][Full Text] [Related]
23. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
Tandberg DJ; Tong BC; Ackerson BG; Kelsey CR
Cancer; 2018 Feb; 124(4):667-678. PubMed ID: 29266226
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic ablative radiation therapy for primary lung tumors.
Heinzerling JH; Kavanagh B; Timmerman RD
Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
26. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
[TBL] [Abstract][Full Text] [Related]
27. [Salvage surgery for locally recurrent lung cancer: options for patients who have been treated with high dose radiotherapy].
Dickhoff C; Hashemi SMS; Symersky P; Paul MA; Dahele M
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040314
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.
Cao C; Wang D; Chung C; Tian D; Rimner A; Huang J; Jones DR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):362-373.e8. PubMed ID: 30482524
[TBL] [Abstract][Full Text] [Related]
29. Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy.
Faruqi S; Giuliani ME; Raziee H; Yap ML; Roberts H; Le LW; Brade A; Cho J; Sun A; Bezjak A; Hope AJ
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1076-1083. PubMed ID: 25035211
[TBL] [Abstract][Full Text] [Related]
30. If at First You Don't Succeed-Stereotactic Body Radiation Therapy for Recurrent Non-Small Cell Lung Cancer.
Owen D; Siva S; Salama JK; Robinson C; Kruser TJ; Giuliani M
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):5-9. PubMed ID: 35964631
[No Abstract] [Full Text] [Related]
31. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
Temming S; Kocher M; Stoelben E; Hagmeyer L; Chang DH; Frank K; Hekmat K; Wolf J; Baus WW; Semrau R; Baues C; Marnitz S
Strahlenther Onkol; 2018 Feb; 194(2):91-97. PubMed ID: 28812120
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer.
Hiraoka M; Matsuo Y; Nagata Y
Cancer Radiother; 2007; 11(1-2):32-5. PubMed ID: 17158081
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC).
Janssen S; Käsmann L; Rudat V; Rades D
Anticancer Res; 2016 Feb; 36(2):825-8. PubMed ID: 26851047
[TBL] [Abstract][Full Text] [Related]
34. Radiological changes after stereotactic radiotherapy for stage I lung cancer.
Dahele M; Palma D; Lagerwaard F; Slotman B; Senan S
J Thorac Oncol; 2011 Jul; 6(7):1221-8. PubMed ID: 21623237
[TBL] [Abstract][Full Text] [Related]
35. Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.
Dan T; Williams NL
Surg Oncol Clin N Am; 2017 Jul; 26(3):393-403. PubMed ID: 28576179
[TBL] [Abstract][Full Text] [Related]
36. Sublobar/wedge resection or stereotactic body radiation therapy for stage I marginally operable non-small-cell lung cancer.
Suppiah S; Linden P; Robke J; Schroeder C; Yao M; Machtay M; Lo SS
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1375-7. PubMed ID: 23249103
[No Abstract] [Full Text] [Related]
37. Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
Poullis M
J Thorac Oncol; 2016 May; 11(5):e64-e65. PubMed ID: 27131296
[No Abstract] [Full Text] [Related]
38. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future.
Hamaji M
Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):692-696. PubMed ID: 31667707
[TBL] [Abstract][Full Text] [Related]
39. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
Timmerman RD; Fernando HC
Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee.
Buyyounouski MK; Balter P; Lewis B; D'Ambrosio DJ; Dilling TJ; Miller RC; Schefter T; Tomé W; Harris EE; Price RA; Konski AA; Wallner PE
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):3-10. PubMed ID: 20643514
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
